The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-8.7% to $70.00
Predicted High$76.90in 2 weeks
Predicted Low$70.00at 6 months
Max Drawdown (predicted)-8.7%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 16, 2026 12:44 am
Bear
CTVA trends lower to
$70.00
(-8.7% from $76.68)
by Feb 2027.
decay
ThesisCTVA trades roughly 80% above composite fair value with weak value lens and negative sentiment tilt, but risk-on tape and 5/5 earnings beats support near-term stickiness. Expect a gradual drift lower as valuation gravity reasserts, accelerating if the risk-on regime cools.
Invalidated ifA break above $82 on strong volume or a Q3 beat-and-raise catalyzing new highs would invalidate the mean-reversion path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $76.68 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 16, 2026
—
$76.68at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 30, 2026
$71.58–$81.78typical range · internal point $76.90
—
±6.6%
7/10
Risk-on tape, low beta, no near-term catalyst
1 month
Sep 16, 2026
$69.30–$84.06typical range · internal point $76.10
—
±9.6%
6/10
Mild drift as momentum cools into fall
2 months
Oct 16, 2026
$74.80
—
-2.5%
5/10
Valuation gravity begins; possible Q3 print pressure
3 months
Nov 16, 2026
$73.20
—
-4.5%
5/10
Post-earnings digestion, sentiment fade risk
4 months
Dec 16, 2026
$72.00
—
-6.1%
4/10
Year-end positioning; stretched multiple weighs
5 months
Jan 16, 2027
$71.00
—
-7.4%
4/10
January reset, ag-cycle guidance uncertainty
6 months
Feb 16, 2027
$70.00
—
-8.7%
4/10
Continued convergence toward baseline endpoint
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$70.42
(-8.2%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.